Outcome of Board Meeting held on Thursday, 13th November, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved unaudited financial results for Q2 and H1 FY26 (ended September 30, 2025). Revenue from operations declined to Rs 1,838.20 lakhs in Q2 FY26 from Rs 1,977.43 lakhs in Q2 FY25, a drop of around 7%. Net profit fell more sharply to Rs 78.60 lakhs from Rs 120.12 lakhs, down roughly 35% year-on-year, pulling H1 FY26 net profit down to Rs 177.94 lakhs versus Rs 215.63 lakhs last year. Operating margins also tightened as raw material and other expense pressures continued. On the positive side, operating cash flow improved to Rs 280.17 lakhs (vs Rs 94.23 lakhs), and the company raised equity of Rs 358.80 lakhs via a preferential allotment to promoters at Rs 52 per share in May 2025, strengthening the balance sheet. The Board also approved a revision in Managing Director Mr. Tushar Patel's remuneration and his re-appointment for a three-year term effective August 1, 2026, subject to shareholder approval via postal ballot.
Shareholders will see weaker top line and significantly weaker bottom line in the September quarter, though the equity infusion and stronger cash generation cushion the outlook. The MD re-appointment signals continuity in leadership but the postal ballot for remuneration revision warrants shareholder attention.